In an OVA-induced allergic rhinitis model, oral treatment with naringenin improved nasal symptoms and decreased serum total IgE and Th2 cytokines IL-4 and IL-5 compared with the OVA treated group [86]. Here, IL4 is linked to allergic rhinitis.